Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene Walks the Neutral Path
Yahoo/Zacks
Saturday, September 8, 2012 - 10:52am
tags:
Celgene Corporation
Peregrine Shares SHOOT The Moon, Opexa’s New AGREEMENT
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:51am
tags:
Peregrine Pharmaceuticals, Opexa, bavituximab, non-small cell lung cancer, Neptune Technologies & Bioresources
Healthcare Business Update: Sarepta Shares REBOUND, Glaxo Goes TRADITIONAL Chinese
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:49am
tags:
Sarepta Therapeutics, eteplirsen, Duchenne Muscular Dystrophy, Questcor Pharmaceuticals, Acthar, GSK, Merge Healthcare
BioDelivery Sciences International: Making The Most Of This Small-Cap Opportunity
Seeking Alpha
Saturday, September 8, 2012 - 10:44am
tags:
BioDelivery Sciences
Amgen Inc: Today's Featured Drugs Laggard
The Street
Saturday, September 8, 2012 - 10:43am
tags:
Amgen
Questcor Rises After Strong Shipping Numbers: Los Angeles Mover
Bloomberg
Saturday, September 8, 2012 - 10:41am
tags:
Questcor, Acthar, multiple sclerosis
This New Cancer Drug is Boosting Peregrine Pharmaceuticals 48%!
Wall Street Cheat Street
Saturday, September 8, 2012 - 10:40am
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer
Vivus' 60 Critical Minutes That Could Double Qsymia's Addressable Market
Seeking Alpha
Saturday, September 8, 2012 - 10:38am
tags:
Vivus, Qsymia, weight loss, obesity
Pipeline Progress at CELG, Shares Up
Yahoo/Zacks
Saturday, September 8, 2012 - 10:37am
tags:
PALACE-2, PALACE-3, Celgene, psoriatic arthritis
Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Friday, September 7, 2012 - 12:22pm
tags:
Roche, cancer, Rituxan, biosimilars
3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits
Reuters
Friday, September 7, 2012 - 12:16pm
tags:
Nexium, pay-for-delay, AstraZeneca, Merck
Celgene Arthritis Treatment Meets Primary Goals in Study
NASDAQ.com
Friday, September 7, 2012 - 12:14pm
tags:
Celgene, apremilast, psoriatic arthritis
AstraZeneca evaluating Starpharma cancer drugs
LifeScientist.au
Friday, September 7, 2012 - 12:13pm
tags:
cancer, AstraZeneca, Starpharma
KV Pharma Loses Lawsuit Against FDA Over Makena
Pharmalot
Friday, September 7, 2012 - 12:07pm
tags:
KV Pharmaceutical, FDA, Makena, premature birth
Dr. Reddy's Laboratories Increases Sales but Misses Estimates on Earnings
Motley Fool
Friday, September 7, 2012 - 12:06pm
tags:
earnings, Dr Reddy's
Pharmacyclics Management Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Friday, September 7, 2012 - 12:04pm
tags:
earnings, Pharmacyclics
Elan Takes Another Swing
Motley Fool
Friday, September 7, 2012 - 12:04pm
tags:
Elan, ELND005, bipolar disorder
Why Is Carl Icahn Buying Large Blocks Of Forest Laboratories?
Seeking Alpha
Friday, September 7, 2012 - 12:03pm
tags:
Forest Labs, Carl Icahn
Shire settles 1 Intuniv patent infringement lawsuit; Anchen can market generic in July 2016
Yahoo/AP
Friday, September 7, 2012 - 12:02pm
tags:
Shire, Intuniv, patents, Anchen, TWi Pharmaceuticals
Sanofi Reaches New 52-Week High
TheStreet.com
Friday, September 7, 2012 - 11:33am
tags:
Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.